Ora, the leading global ophthalmic contract research organization (CRO), is excited to announce that it has been recapitalized by The Vistria Group, a middle-market private investment firm that seeks to deliver both financial returns and societal impact. With this investment, The Vistria Group will support Ora as the globally preferred clinical research partner of ophthalmic innovators. It also marks The Vistria Group’s commitment to further supporting cutting-edge therapies and advancing diversity in specialized clinical research. Ora is the seventh company in The Vistria Group’s pharma services portfolio and underscores the firm’s continued focus on life sciences.
Read the full article: Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research //
Source: https://www.businesswire.com/news/home/20240719985823/en/Ora-Announces-Strategic-Investment-from-The-Vistria-Group-to-Propel-Global-Growth-Enhance-Customer-Experience-in-Ophthalmic-Research